Overview and Scope
Hemostasis analyzers are devices that measure clotting mechanisms of hemostasis to detect clotting deficiencies. The natural ability of the body to stop bleeding quickly in order to stop serious blood loss is known as hemostasis.
Sizing and Forecast
The hemostasis analyzers market size has grown strongly in recent years. It will grow from $4.84 billion in 2023 to $5.19 billion in 2024 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to growing prevalence of bleeding disorders, aging population, increased surgical procedures, rise in hemostatic disorders.
The hemostasis analyzers market size is expected to see strongly grown in the next few years. It will grow to $6.89 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to personalized medicine, global health concerns, rising chronic diseases, growing investment in hemostasis analyzer infrastructure. Major trends in the forecast period include advances in hemostasis analyzer technology, point-of-care hemostasis testing, biomarker-based monitoring, telemedicine integration, data analytics and artificial intelligence.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/hemostasis-analyzers-global-market-report
Segmentation & Regional Insights
The hemostasis analyzers market covered in this report is segmented –
1) By Product: Clinical Laboratory Analyzers, Point-Of-Care Testing Analyzers, Consumables
2) By Test: APTT Tests, D Dimer Tests, Platelet Function Tests, Fibrinogen Tests, Prothrombin Time Tests, Other Tests
3) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology, Other Technologies
4) By End Use: Hospitals & Clinics, Diagnostic Centers, Research And Development Organisations, Ambulatory Surgical Centers, Other End Uses
North America was the largest region in the hemostasis analyzers market in 2023. Western Europe was the second-largest region in the hemostasis analyzers market report. The regions covered in the hemostasis analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample_request?id=2545&type=smp
Major Driver Impacting Market Growth
Increasing awareness regarding blood disorder conditions is driving the hemostasis analyzers market. Blood disorders such as Hemophilia and Von Willebrand disease (vWD) are genetic disorders and are not well known to people. This results in late diagnosis of blood disorders affecting the patients. For instance, the National Haemophilia Foundation’s Red Tie Campaign is raising awareness about treatment for bleeding disorders like hemophilia, leukemia, myeloma, and lymphoma for approximately 3 million people in the USA with bleeding disorders. The Haemophilia Foundation Australia is an organization that is working towards the wellbeing of people affected by blood disorders through education, advocacy, and the promotion of research. Increasing awareness is expected to improve the diagnosis rate of blood disorders driving the demand for hemostasis analyzers.
Key Industry Players
Major companies operating in the hemostasis analyzers market include Thermo Fisher Scientific Inc., Alere Inc., Siemens AG, F-Hoffmann La Roche, Nihon Kohden Corporation, Sysmex Corporation, Helena Laboratories, International Technidyne Corporation, Instrumentation Laboratory (A Division of the Werfen Group), Abbott Laboratories, Diagnostica Stago Inc., Grifols S.A., Beckman Coulter Inc., Diamond Diagnostics, Mindray Medical International Limited, Horiba Ltd., Becton Dickinson and Company, Transasia Bio-Medicals Ltd., Instrumentation Laboratory, Medtronic Inc., F. Hoffmann-La Roche AG, Sekisui Diagnostics, Stago, Technoclone, Trinity Biotech PLC, Werfen S.A., Zymo Research, ACON LABS INC., Accriva Diagnostics
The hemostasis analyzers market report table of contents includes:
1. Executive Summary
2. Hemostasis Analyzers Market Characteristics
3. Hemostasis Analyzers Market Trends And Strategies
4. Hemostasis Analyzers Market – Macro Economic Scenario
5. Global Hemostasis Analyzers Market Size and Growth
.
.
.
31. Global Hemostasis Analyzers Market Competitive Benchmarking
32. Global Hemostasis Analyzers Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Hemostasis Analyzers Market
34. Hemostasis Analyzers Market Future Outlook and Potential Analysis
35. Appendix
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The structural heart devices global market report 2024from The Business Research Company provides comprehensive market…
The genetic toxicology testing global market report 2024from The Business Research Company provides comprehensive market…
The reservation and online booking software global market report 2024from The Business Research Company provides…
The land management software global market report 2024from The Business Research Company provides comprehensive market…
The quality management software global market report 2024from The Business Research Company provides comprehensive market…
The iliac stent global market report 2024from The Business Research Company provides comprehensive market statistics,…